An Open Label, Prospective, Randomised, Comparative, Two Arm Clinical Study to Evaluate the Effectiveness, Safety and Tolerability of Kesh21 Ayurvedic Hair Oil and Kesh 21 Ayurvedic Shampoo in Comparison with Coconut Oil and Regular Shampoo in the Management of Alopecia, Seborrheic Dermatitis of the Scalp, Premature Greying and Trichoptilosis in Adults

Ontop Pharmaceuticals Pvt Ltd0 个研究点目标入组 42 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Subjects between the age group of 21 to 45 years.
•2.Subjects who are able to give written informed consent and ready to comply with the protocol.
•3.Subjects with
•i.Active Alopecia,
•ii.Seborrheic Dermatitis of the Scalp - Total ASFS Score >= 16,
•iii.Premature Greying - â??Gray Hair Shade Card Assessment >=50%
•iv.Trichoptilosis (selected section of hair)
•4.Subjects with a minimum hair length of 2 inches.
•5.Subjects who are willing to maintain the same hair length and hair style from the time of enrolment till end of study, without anybleaching, dyeing, perming, straightening or other cosmetic treatments

•1.Subjects on topical treatment for alopecia, premature graying of the hair and seborrheic dermatitis for 8 weeks prior to enrollment.
•2.Subjects with alopecia areata or other disorders/complications that lead to unusual hair fall or balding.
•3.Subjects who are balding or bald.
•4.Subjects who have used hair dye in the last 30 days or intend on regular use of hair dye during the course of the study
•5.Subject with other dermatological disorders of the scalp that might interfere with the study evaluation.
•6.Subjects with significant scalp scarring.
•7.Subjects who have anemia or iron deficiency.
•8.Subjects who have previously undergone hair transplantation procedures.
•9.History of systemic or cutaneous malignancy or evidence of immunocompromised state.
•10.Subjects with history of skin allergy.
•11.Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
•12.Female subjects who are reported pregnant/planning a pregnancy or lactating.
•13.Subjects who are currently enrolled in an active investigational study or have participated in an investigational study within 30 days prior to enrolment.
•14.Subjects, who in the opinion of the Investigator or the Expert Dermatologist are not eligible for enrolment in the study

发起方

Ontop Pharmaceuticals Pvt Ltd